Skip to content

Chicago Classification Normative Metrics in a Healthy Russian Cohort According to High-resolution Esophageal Manometry

Chicago Classification Normative Metrics in a Healthy Russian Cohort According to High-resolution Esophageal Manometry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03829865
Enrollment
80
Registered
2019-02-04
Start date
2019-02-04
Completion date
2023-12-31
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

High resolution esophageal manometry normative values are still need to be studied in different populations and with the use of solid-state and water-perfused systems. There has been no study on the subject in healthy Russian population yet.

Detailed description

High-resolution esophageal manometry (HREM) is the current modality used to evaluate esophageal motility. There are 2 types of system: water-perfused system that is cheaper to maintain and a solid-state system that is considered to be more sensitive. According to the data obtained in the study of 400 patients and 75 controls by J Pandolfino et al it was proposed to use a common algorithm of HREM data interpretation and the normative values of the parameters used to interpret the color plots of HREM. This formed the basis for the first version of the currently used HREM reporting algorithm and classification of esophageal motility disorders called Chicago Classification (CC). To date, this classification has been updated several times by the International Working Group based on the recently published data. The Working group stated that the proposed normative values still need to be widely studied for each HREM system and in different populations. Some studies has been published recently on the normative values of HREM in different countries (predominantly in the US, in some European countries, Korea, India and China. But there has been no study on the subject in Russia still.

Interventions

High resolution esophageal manometry will be performed to eligible subjects willing to participate in the study

Sponsors

Russian Academy of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

(all points are necessary for inclusion): * Willingness to participate on the basis of signed informed consent form; * Patients of both sexes, aged 18 to 65 years inclusive; * Permanent residence in the Russian Federation; * Absence of esophageal diseases, confirmed by the results of clinical and instrumental examination * Ability to follow instructions during high-resolution esophageal manometry procedure

Exclusion criteria

(patient is not eligible when at least one exclusion criterion is met): * diseases of the esophagus (any condition on the basis of clinical and / or instrumental examination, including: complaints of heartburn, belching, difficulty to swallow solid and/or liquid food; * any surgical intervention on the gastrointestinal tract and / or chest organs in medical history; * solid organ transplantation in medical history with the exception of a corneal transplant and surgery to replace the lens of the eye; * any oncology of any localization except for skin cancer in situ in the medical history; * any decompensated diseases of any organs and systems, which, in the opinion of the researcher, makes it impossible to carry out the procedure of esophageal manometry of high resolution or if the procedure may cause the risk of deterioration of the patient's condition; * any condition, clinical and laboratory signs of alcohol abuse (abuse will be assessed in the case of male subjects consuming more than 30 g of pure alcohol per day and using more than 20 g of pure alcohol per day by female subjects; * any illegal drug use, current or past; * use of concomitant medications that can affect esophageal motility including, but not limited to: calcium channel blockers, metoclopramide, m-cholinolytics, domperidone, erythromycin, nitrates, tricyclic antidepressants, opiates, beta-blockers, beta-adrenomimetics, alcohol. The duration of the period of non-use of these drugs should provide sufficient time for the complete cessation of their pharmacological action, but not less than two half-life. * pregnant or breastfeeding women * any condition making impossible to perform high resolution esophageal manometry (previously known poor tolerability of the procedure; narrow nasal passages; significant curvature of the nasal septum etc).

Design outcomes

Primary

MeasureTime frameDescription
Mean IRPmean value of 10 swallows by 30 seconds (about 7 minutes per subject)Integrated Relaxation Pressure - mean of the 4 s of maximal deglutitive relaxation in the 10-s window beginning at upper esophageal sphincter relaxation
Mean DCImean value of 10 swallows by 30 seconds (about 7 minutes per subject)distal contractile integral - Amplitude x duration x length (mmHg x s x cm) of the distal esophageal contraction exceeding 20 mmHg from the transition zone to the proximal margin of the LES
Mean DLmean value of 10 swallows by 30 seconds (about 7 minutes per subject)distal latency - Interval between UES relaxation and the contractile deceleration point
Mean upper esophageal sphincter mean resting pressuremean value based on 30 seconds measurement of a subjectmean pressure of the upper esophageal sphincter
Mean lower esophageal sphincter mean resting pressuremean value based on 30 seconds measurement of a subjectmean pressure of the upper esophageal sphincter

Countries

Russia

Contacts

Primary ContactSergey Morozov, MD, PhD
morosoffsv@mail.ru+74996131091

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026